Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roelf Valkema

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2007
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidneyEdgar J Rolleman, Peter P M Kooij, Wouter W de Herder, et al.
Hematology/Oncology Clinics of North America|June 6, 2007
Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analoguesDik J Kwekkeboom, Jaap J M Teunissen, Boen L Kam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2011
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?Stephan Walrand, Glenn D Flux, Mark W Konijnenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Prognostic stratification of obese patients by stress 99mTc-tetrofosmin myocardial perfusion imagingAbdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2006
Prognostic value of stress 99mTc-tetrofosmin myocardial perfusion imaging in predicting all-cause mortality: a 6-year follow-up studyAbdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 1, 2016
Ischemia burden on stress SPECT MPI predicts long-term outcomes after revascularization in stable coronary artery diseaseHendrik J Boiten, Jan C van den Berge, Roelf Valkema, et al.
Current Alzheimer Research|September 29, 2012
Episodic memory impairment in frontotemporal dementia; a ⁹⁹mTc- HMPAO SPECT studyJanne M Papma, Harro Seelaar, Inge de Koning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2005
Association of ischemia on stress (99m)Tc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitusAbdou Elhendy, Aukje Huurman, Arend F L Schinkel, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2007
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidneyEdgar J Rolleman, Peter P M Kooij, Wouter W de Herder, et al.
Hematology/Oncology Clinics of North America|June 6, 2007
Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analoguesDik J Kwekkeboom, Jaap J M Teunissen, Boen L Kam, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2011
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?Stephan Walrand, Glenn D Flux, Mark W Konijnenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Prognostic stratification of obese patients by stress 99mTc-tetrofosmin myocardial perfusion imagingAbdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogsStanislas Pauwels, Raffaella Barone, Stéphan Walrand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2006
Prognostic value of stress 99mTc-tetrofosmin myocardial perfusion imaging in predicting all-cause mortality: a 6-year follow-up studyAbdou Elhendy, Arend F L Schinkel, Ron T van Domburg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 1, 2016
Ischemia burden on stress SPECT MPI predicts long-term outcomes after revascularization in stable coronary artery diseaseHendrik J Boiten, Jan C van den Berge, Roelf Valkema, et al.
Current Alzheimer Research|September 29, 2012
Episodic memory impairment in frontotemporal dementia; a ⁹⁹mTc- HMPAO SPECT studyJanne M Papma, Harro Seelaar, Inge de Koning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2005
Association of ischemia on stress (99m)Tc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitusAbdou Elhendy, Aukje Huurman, Arend F L Schinkel, et al.
Pageof 10